{"id":2023,"date":"2014-11-24T11:22:52","date_gmt":"2014-11-24T11:22:52","guid":{"rendered":"https:\/\/blogs.bmj.com\/jfprhc\/?p=2023"},"modified":"2014-11-24T11:22:52","modified_gmt":"2014-11-24T11:22:52","slug":"ema-recommends-availability-of-ellaone-emergency-contraceptive-without-prescription","status":"publish","type":"post","link":"https:\/\/blogs.bmj.com\/bmjsrh\/2014\/11\/24\/ema-recommends-availability-of-ellaone-emergency-contraceptive-without-prescription\/","title":{"rendered":"EMA recommends availability of ellaOne\u00ae emergency contraceptive without prescription"},"content":{"rendered":"<p><strong>Change in status to facilitate access for women across Europe<br \/>\n<\/strong><\/p>\n<p>The <a href=\"http:\/\/www.ema.europa.eu\/ema\/index.jsp?curl=pages\/news_and_events\/news\/2014\/11\/news_detail_002223.jsp&amp;mid=WC0b01ac058004d5c1\" target=\"_blank\">European Medicines Agency\u2019s<\/a> <span class=\"glossary-term\">Committee for Medicinal Products for Human Use<\/span> (<span class=\"glossary-term\">CHMP<\/span>) has recommended a change in classification status from prescription to non-prescription for the emergency contraceptive ellaOne<sup>\u00ae <\/sup>(ulipristal acetate). This means that the medicine could be obtained without a prescription in the European Union (EU).<\/p>\n<p>This recommendation is the first-ever of its type regarding an oral contraceptive product, which should apply in all EU member states in 2015, after a final endorsement by the European Commission.<\/p>\n<p>ellaOne<sup>\u00ae <\/sup>first became available in Europe with a medical prescription at the end of 2009. This was then followed by its launch in the United States in 2010 after approval by the Food and Drug Administration (FDA). These approvals were based on full clinical tests and research. ellaOne<sup>\u00ae\u00a0 <\/sup>has already been used by more than 3 million women in 70 countries over the past 5 years.<\/p>\n<p>Based on the assessment of available data, the CHMP found that ellaOne<sup>\u00ae <\/sup>can be used safely and effectively without medical prescription.<\/p>\n<p><span lang=\"EN-US\">Professor Anna Glasier, from the University of Edinburgh (Scotland), agreed that the newly announced enhanced access for women is a key milestone and said, \u201cellaOne<sup>\u00ae<\/sup> is a highly effective emergency contraceptive which we\u2019ve been using for 5 years now, and making it more accessible and available more quickly from pharmacies is a logical and sensible thing to do. Women need to get access to emergency contraception as soon as possible in order to be in the best position to avoid an unintended pregnancy; this is a matter of public health\u201d. <\/span><\/p>\n<p>This CHMP recommendation will now be sent to the European Commission for a legally binding decision within 2 months.<br \/>\nHRA Pharma expects ellaOne<sup>\u00ae <\/sup>to be available directly from pharmacies in 2015 across the European Union.<!--TrendMD v2.4.8--><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Change in status to facilitate access for women across Europe The European Medicines Agency\u2019s Committee for Medicinal Products for Human Use (CHMP) has recommended a change in classification status from prescription to non-prescription for the emergency contraceptive ellaOne\u00ae (ulipristal acetate). This means that the medicine could be obtained without a prescription in the European Union [&#8230;]<\/p>\n<p><a class=\"btn btn-secondary understrap-read-more-link\" href=\"https:\/\/blogs.bmj.com\/bmjsrh\/2014\/11\/24\/ema-recommends-availability-of-ellaone-emergency-contraceptive-without-prescription\/\">Read More&#8230;<\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[599],"tags":[],"class_list":["post-2023","post","type-post","status-publish","format-standard","hentry","category-screening"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.6 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>EMA recommends availability of ellaOne\u00ae emergency contraceptive without prescription - BMJ Sexual &amp; Reproductive Health blog<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/blogs.bmj.com\/bmjsrh\/2014\/11\/24\/ema-recommends-availability-of-ellaone-emergency-contraceptive-without-prescription\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"EMA recommends availability of ellaOne\u00ae emergency contraceptive without prescription - BMJ Sexual &amp; Reproductive Health blog\" \/>\n<meta property=\"og:description\" content=\"Change in status to facilitate access for women across Europe The European Medicines Agency\u2019s Committee for Medicinal Products for Human Use (CHMP) has recommended a change in classification status from prescription to non-prescription for the emergency contraceptive ellaOne\u00ae (ulipristal acetate). This means that the medicine could be obtained without a prescription in the European Union [...]Read More...\" \/>\n<meta property=\"og:url\" content=\"https:\/\/blogs.bmj.com\/bmjsrh\/2014\/11\/24\/ema-recommends-availability-of-ellaone-emergency-contraceptive-without-prescription\/\" \/>\n<meta property=\"og:site_name\" content=\"BMJ Sexual &amp; Reproductive Health blog\" \/>\n<meta property=\"article:published_time\" content=\"2014-11-24T11:22:52+00:00\" \/>\n<meta name=\"author\" content=\"BMJ\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"BMJ\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/bmjsrh\\\/2014\\\/11\\\/24\\\/ema-recommends-availability-of-ellaone-emergency-contraceptive-without-prescription\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/bmjsrh\\\/2014\\\/11\\\/24\\\/ema-recommends-availability-of-ellaone-emergency-contraceptive-without-prescription\\\/\"},\"author\":{\"name\":\"BMJ\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/bmjsrh\\\/#\\\/schema\\\/person\\\/ba3da426ed20e8f1d933ca367d8216fe\"},\"headline\":\"EMA recommends availability of ellaOne\u00ae emergency contraceptive without prescription\",\"datePublished\":\"2014-11-24T11:22:52+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/bmjsrh\\\/2014\\\/11\\\/24\\\/ema-recommends-availability-of-ellaone-emergency-contraceptive-without-prescription\\\/\"},\"wordCount\":301,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/bmjsrh\\\/#organization\"},\"articleSection\":[\"screening\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/blogs.bmj.com\\\/bmjsrh\\\/2014\\\/11\\\/24\\\/ema-recommends-availability-of-ellaone-emergency-contraceptive-without-prescription\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/bmjsrh\\\/2014\\\/11\\\/24\\\/ema-recommends-availability-of-ellaone-emergency-contraceptive-without-prescription\\\/\",\"url\":\"https:\\\/\\\/blogs.bmj.com\\\/bmjsrh\\\/2014\\\/11\\\/24\\\/ema-recommends-availability-of-ellaone-emergency-contraceptive-without-prescription\\\/\",\"name\":\"EMA recommends availability of ellaOne\u00ae emergency contraceptive without prescription - BMJ Sexual &amp; Reproductive Health blog\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/bmjsrh\\\/#website\"},\"datePublished\":\"2014-11-24T11:22:52+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/bmjsrh\\\/2014\\\/11\\\/24\\\/ema-recommends-availability-of-ellaone-emergency-contraceptive-without-prescription\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/blogs.bmj.com\\\/bmjsrh\\\/2014\\\/11\\\/24\\\/ema-recommends-availability-of-ellaone-emergency-contraceptive-without-prescription\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/bmjsrh\\\/2014\\\/11\\\/24\\\/ema-recommends-availability-of-ellaone-emergency-contraceptive-without-prescription\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/blogs.bmj.com\\\/bmjsrh\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"EMA recommends availability of ellaOne\u00ae emergency contraceptive without prescription\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/bmjsrh\\\/#website\",\"url\":\"https:\\\/\\\/blogs.bmj.com\\\/bmjsrh\\\/\",\"name\":\"BMJ Sexual &amp; Reproductive Health blog\",\"description\":\"For readers of the journal and health professionals in contraception and sexual health care.\",\"publisher\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/bmjsrh\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/blogs.bmj.com\\\/bmjsrh\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/bmjsrh\\\/#organization\",\"name\":\"BMJ Sexual &amp; Reproductive Health blog\",\"url\":\"https:\\\/\\\/blogs.bmj.com\\\/bmjsrh\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/bmjsrh\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/blogs.bmj.com\\\/bmjsrh\\\/files\\\/2017\\\/11\\\/blog-logo-bmj-srh.png\",\"contentUrl\":\"https:\\\/\\\/blogs.bmj.com\\\/bmjsrh\\\/files\\\/2017\\\/11\\\/blog-logo-bmj-srh.png\",\"width\":328,\"height\":34,\"caption\":\"BMJ Sexual &amp; Reproductive Health blog\"},\"image\":{\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/bmjsrh\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/blogs.bmj.com\\\/bmjsrh\\\/#\\\/schema\\\/person\\\/ba3da426ed20e8f1d933ca367d8216fe\",\"name\":\"BMJ\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/b4d8f39281bcae118348a1c027347b8e53b82d42520e774a8b50dd9a6ac6c01d?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/b4d8f39281bcae118348a1c027347b8e53b82d42520e774a8b50dd9a6ac6c01d?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/b4d8f39281bcae118348a1c027347b8e53b82d42520e774a8b50dd9a6ac6c01d?s=96&d=mm&r=g\",\"caption\":\"BMJ\"},\"sameAs\":[\"https:\\\/\\\/blogs.bmj.com\\\/\"],\"url\":\"https:\\\/\\\/blogs.bmj.com\\\/bmjsrh\\\/author\\\/admin\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"EMA recommends availability of ellaOne\u00ae emergency contraceptive without prescription - BMJ Sexual &amp; Reproductive Health blog","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/blogs.bmj.com\/bmjsrh\/2014\/11\/24\/ema-recommends-availability-of-ellaone-emergency-contraceptive-without-prescription\/","og_locale":"en_US","og_type":"article","og_title":"EMA recommends availability of ellaOne\u00ae emergency contraceptive without prescription - BMJ Sexual &amp; Reproductive Health blog","og_description":"Change in status to facilitate access for women across Europe The European Medicines Agency\u2019s Committee for Medicinal Products for Human Use (CHMP) has recommended a change in classification status from prescription to non-prescription for the emergency contraceptive ellaOne\u00ae (ulipristal acetate). This means that the medicine could be obtained without a prescription in the European Union [...]Read More...","og_url":"https:\/\/blogs.bmj.com\/bmjsrh\/2014\/11\/24\/ema-recommends-availability-of-ellaone-emergency-contraceptive-without-prescription\/","og_site_name":"BMJ Sexual &amp; Reproductive Health blog","article_published_time":"2014-11-24T11:22:52+00:00","author":"BMJ","twitter_card":"summary_large_image","twitter_misc":{"Written by":"BMJ","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/blogs.bmj.com\/bmjsrh\/2014\/11\/24\/ema-recommends-availability-of-ellaone-emergency-contraceptive-without-prescription\/#article","isPartOf":{"@id":"https:\/\/blogs.bmj.com\/bmjsrh\/2014\/11\/24\/ema-recommends-availability-of-ellaone-emergency-contraceptive-without-prescription\/"},"author":{"name":"BMJ","@id":"https:\/\/blogs.bmj.com\/bmjsrh\/#\/schema\/person\/ba3da426ed20e8f1d933ca367d8216fe"},"headline":"EMA recommends availability of ellaOne\u00ae emergency contraceptive without prescription","datePublished":"2014-11-24T11:22:52+00:00","mainEntityOfPage":{"@id":"https:\/\/blogs.bmj.com\/bmjsrh\/2014\/11\/24\/ema-recommends-availability-of-ellaone-emergency-contraceptive-without-prescription\/"},"wordCount":301,"commentCount":0,"publisher":{"@id":"https:\/\/blogs.bmj.com\/bmjsrh\/#organization"},"articleSection":["screening"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/blogs.bmj.com\/bmjsrh\/2014\/11\/24\/ema-recommends-availability-of-ellaone-emergency-contraceptive-without-prescription\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/blogs.bmj.com\/bmjsrh\/2014\/11\/24\/ema-recommends-availability-of-ellaone-emergency-contraceptive-without-prescription\/","url":"https:\/\/blogs.bmj.com\/bmjsrh\/2014\/11\/24\/ema-recommends-availability-of-ellaone-emergency-contraceptive-without-prescription\/","name":"EMA recommends availability of ellaOne\u00ae emergency contraceptive without prescription - BMJ Sexual &amp; Reproductive Health blog","isPartOf":{"@id":"https:\/\/blogs.bmj.com\/bmjsrh\/#website"},"datePublished":"2014-11-24T11:22:52+00:00","breadcrumb":{"@id":"https:\/\/blogs.bmj.com\/bmjsrh\/2014\/11\/24\/ema-recommends-availability-of-ellaone-emergency-contraceptive-without-prescription\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/blogs.bmj.com\/bmjsrh\/2014\/11\/24\/ema-recommends-availability-of-ellaone-emergency-contraceptive-without-prescription\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/blogs.bmj.com\/bmjsrh\/2014\/11\/24\/ema-recommends-availability-of-ellaone-emergency-contraceptive-without-prescription\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/blogs.bmj.com\/bmjsrh\/"},{"@type":"ListItem","position":2,"name":"EMA recommends availability of ellaOne\u00ae emergency contraceptive without prescription"}]},{"@type":"WebSite","@id":"https:\/\/blogs.bmj.com\/bmjsrh\/#website","url":"https:\/\/blogs.bmj.com\/bmjsrh\/","name":"BMJ Sexual &amp; Reproductive Health blog","description":"For readers of the journal and health professionals in contraception and sexual health care.","publisher":{"@id":"https:\/\/blogs.bmj.com\/bmjsrh\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/blogs.bmj.com\/bmjsrh\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/blogs.bmj.com\/bmjsrh\/#organization","name":"BMJ Sexual &amp; Reproductive Health blog","url":"https:\/\/blogs.bmj.com\/bmjsrh\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/blogs.bmj.com\/bmjsrh\/#\/schema\/logo\/image\/","url":"https:\/\/blogs.bmj.com\/bmjsrh\/files\/2017\/11\/blog-logo-bmj-srh.png","contentUrl":"https:\/\/blogs.bmj.com\/bmjsrh\/files\/2017\/11\/blog-logo-bmj-srh.png","width":328,"height":34,"caption":"BMJ Sexual &amp; Reproductive Health blog"},"image":{"@id":"https:\/\/blogs.bmj.com\/bmjsrh\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/blogs.bmj.com\/bmjsrh\/#\/schema\/person\/ba3da426ed20e8f1d933ca367d8216fe","name":"BMJ","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/b4d8f39281bcae118348a1c027347b8e53b82d42520e774a8b50dd9a6ac6c01d?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/b4d8f39281bcae118348a1c027347b8e53b82d42520e774a8b50dd9a6ac6c01d?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/b4d8f39281bcae118348a1c027347b8e53b82d42520e774a8b50dd9a6ac6c01d?s=96&d=mm&r=g","caption":"BMJ"},"sameAs":["https:\/\/blogs.bmj.com\/"],"url":"https:\/\/blogs.bmj.com\/bmjsrh\/author\/admin\/"}]}},"_links":{"self":[{"href":"https:\/\/blogs.bmj.com\/bmjsrh\/wp-json\/wp\/v2\/posts\/2023","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/blogs.bmj.com\/bmjsrh\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/blogs.bmj.com\/bmjsrh\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/blogs.bmj.com\/bmjsrh\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/blogs.bmj.com\/bmjsrh\/wp-json\/wp\/v2\/comments?post=2023"}],"version-history":[{"count":0,"href":"https:\/\/blogs.bmj.com\/bmjsrh\/wp-json\/wp\/v2\/posts\/2023\/revisions"}],"wp:attachment":[{"href":"https:\/\/blogs.bmj.com\/bmjsrh\/wp-json\/wp\/v2\/media?parent=2023"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/blogs.bmj.com\/bmjsrh\/wp-json\/wp\/v2\/categories?post=2023"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/blogs.bmj.com\/bmjsrh\/wp-json\/wp\/v2\/tags?post=2023"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}